BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paramio JM, Navarro M, Segrelles C, Gómez-casero E, Jorcano JL. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 1999;18:7462-8. [DOI: 10.1038/sj.onc.1203151] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Kurose K, Zhou XP, Araki T, Cannistra SA, Maher ER, Eng C. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol 2001;158:2097-106. [PMID: 11395387 DOI: 10.1016/S0002-9440(10)64681-0] [Cited by in Crossref: 177] [Cited by in F6Publishing: 58] [Article Influence: 8.4] [Reference Citation Analysis]
2 Carnero A, Paramio JM. The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models. Front Oncol 2014;4:252. [PMID: 25295225 DOI: 10.3389/fonc.2014.00252] [Cited by in Crossref: 95] [Cited by in F6Publishing: 102] [Article Influence: 11.9] [Reference Citation Analysis]
3 Torosyan Y, Simakova O, Naga S, Mezhevaya K, Leighton X, Diaz J, Huang W, Pollard H, Srivastava M. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells. Int J Cancer 2009;125:2528-39. [PMID: 19610065 DOI: 10.1002/ijc.24592] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
4 Chang CC, Sue YM, Yang NJ, Lee YH, Juan SH. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex. PLoS One 2014;9:e92793. [PMID: 24658119 DOI: 10.1371/journal.pone.0092793] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
5 Venugopal J, Hanashiro K, Yang ZZ, Nagamine Y. Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes. Proc Natl Acad Sci U S A 2004;101:17120-5. [PMID: 15569940 DOI: 10.1073/pnas.0405278101] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
6 Blaheta RA, Michaelis M, Driever PH, Cinatl J Jr. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies. Med Res Rev 2005;25:383-97. [PMID: 15637697 DOI: 10.1002/med.20027] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 8.5] [Reference Citation Analysis]
7 Yin Y, Shen WH. PTEN: a new guardian of the genome. Oncogene 2008;27:5443-53. [PMID: 18794879 DOI: 10.1038/onc.2008.241] [Cited by in Crossref: 241] [Cited by in F6Publishing: 234] [Article Influence: 17.2] [Reference Citation Analysis]
8 Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol 2001;189:1-13. [PMID: 11573199 DOI: 10.1002/jcp.1137] [Cited by in Crossref: 323] [Cited by in F6Publishing: 305] [Article Influence: 15.4] [Reference Citation Analysis]
9 Dupont J, Renou JP, Shani M, Hennighausen L, LeRoith D. PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Invest 2002;110:815-25. [PMID: 12235113 DOI: 10.1172/JCI13829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 36] [Article Influence: 0.1] [Reference Citation Analysis]
10 Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387-390. [PMID: 10693755 DOI: 10.1016/s0092-8674(00)80674-1] [Cited by in Crossref: 807] [Cited by in F6Publishing: 350] [Article Influence: 36.7] [Reference Citation Analysis]
11 Santos M, Paramio JM, Bravo A, Ramirez A, Jorcano JL. The Expression of Keratin K10 in the Basal Layer of the Epidermis Inhibits Cell Proliferation and Prevents Skin Tumorigenesis. Journal of Biological Chemistry 2002;277:19122-30. [DOI: 10.1074/jbc.m201001200] [Cited by in Crossref: 79] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
12 Zhang CL, Zou Y, Yu RT, Gage FH, Evans RM. Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1. Genes Dev 2006;20:1308-20. [PMID: 16702404 DOI: 10.1101/gad.1413606] [Cited by in Crossref: 89] [Cited by in F6Publishing: 94] [Article Influence: 5.6] [Reference Citation Analysis]
13 Cook JA, August A, Henderson AJ. Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism. J Immunol 2002;169:254-60. [PMID: 12077252 DOI: 10.4049/jimmunol.169.1.254] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
14 Kang YH, Ji NY, Lee CI, Lee HG, Kim JW, Yeom YI, Kim DG, Yoon SK, Kim JW, Park PJ, Song EY. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids 2011;40:1003-13. [PMID: 20821239 DOI: 10.1007/s00726-010-0729-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
15 Vallard A, Rancoule C, Espenel S, Garcia MA, Langrand-Escure J, He MY, Ben Mrad M, El Meddeb Hamrouni A, Ouni S, Trone JC, Rehailia-Blanchard A, Guillaume E, Vial N, Riocreux C, Guy JB, Magné N. Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study). Radiother Oncol 2018;129:471-8. [PMID: 29937210 DOI: 10.1016/j.radonc.2018.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Dupont J, Renou JP, Shani M, Hennighausen L, Leroith D. PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium. J Clin Invest 2002;110:815-25. [DOI: 10.1172/jci0213829] [Cited by in Crossref: 63] [Article Influence: 3.2] [Reference Citation Analysis]
17 Li B, Zhang J, Huang T, Zhang L, Cai Y. Identification of retinoblastoma related genes with shortest path in a protein–protein interaction network. Biochimie 2012;94:1910-7. [DOI: 10.1016/j.biochi.2012.05.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
18 Mercapide J, Zhang SY, Fan X, Furió-bacete V, Schneider J, Osa ÍLDL, Patchefsky AS, Klein-szanto AJP, Castresana JS. CCND1 - and ERBB2 -gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast: GENETICS OF LOBULAR BREAST CANCER. Mol Carcinog 2002;35:6-12. [DOI: 10.1002/mc.10069] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
19 Paramio JM, Segrelles C, Ruiz S, Jorcano JL. Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol Cell Biol 2001;21:7449-59. [PMID: 11585925 DOI: 10.1128/MCB.21.21.7449-7459.2001] [Cited by in Crossref: 98] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
20 Wishart MJ, Taylor GS, Slama JT, Dixon JE. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr Opin Cell Biol 2001;13:172-81. [PMID: 11248551 DOI: 10.1016/s0955-0674(00)00195-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
21 Yokoyama A, Igarashi K, Sato T, Takagi K, Otsuka I M, Shishido Y, Baba T, Ito R, Kanno J, Ohkawa Y, Morohashi K, Sugawara A. Identification of myelin transcription factor 1 (MyT1) as a subunit of the neural cell type-specific lysine-specific demethylase 1 (LSD1) complex. J Biol Chem 2014;289:18152-62. [PMID: 24828497 DOI: 10.1074/jbc.M114.566448] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
22 Chen H, Ye D, Xie X, Lu W, Zhu C, Chen X. PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles. Journal of the Society for Gynecologic Investigation 2016;12:214-7. [DOI: 10.1016/j.jsgi.2005.01.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
23 Kim D, Chung J. Akt: Versatile Mediator of Cell Survival and Beyond. BMB Reports 2002;35:106-15. [DOI: 10.5483/bmbrep.2002.35.1.106] [Cited by in Crossref: 78] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
24 Gómez-Casero E, Navarro M, Rodríguez-Puebla ML, Larcher F, Paramio JM, Conti CJ, Jorcano JL. Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol Carcinog. 2001;32:100-109. [PMID: 11746822 DOI: 10.1002/mc.1069] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
25 Okamura H, Yoshida K, Morimoto H, Haneji T. PTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells. J Cell Biochem 2005;94:117-25. [PMID: 15517593 DOI: 10.1002/jcb.20283] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
26 Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, García-escudero R, Martínez-cruz AB, Martínez-palacio J, Hernández P, Ballestín C, Paramio JM. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006;25:1174-85. [DOI: 10.1038/sj.onc.1209155] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 3.9] [Reference Citation Analysis]
27 Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002;70:829-44. [PMID: 11875759 DOI: 10.1086/340026] [Cited by in Crossref: 326] [Cited by in F6Publishing: 279] [Article Influence: 16.3] [Reference Citation Analysis]
28 Segrelles C, Ruiz S, Perez P, Murga C, Santos M, Budunova IV, Martínez J, Larcher F, Slaga TJ, Gutkind JS, Jorcano JL, Paramio JM. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 2002;21:53-64. [DOI: 10.1038/sj.onc.1205032] [Cited by in Crossref: 138] [Cited by in F6Publishing: 123] [Article Influence: 6.9] [Reference Citation Analysis]
29 Kim RD, Darling CE, Roth TP, Ricciardi R, Chari RS. Activator Protein 1 Activation following Hypoosmotic Stress in HepG2 Cells Is Actin Cytoskeleton Dependent. Journal of Surgical Research 2001;100:176-82. [DOI: 10.1006/jsre.2001.6225] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
30 Costa C, Santos M, Segrelles C, Dueñas M, Lara MF, Agirre X, Prosper F, García-Escudero R, Paramio JM. A novel tumor suppressor network in squamous malignancies. Sci Rep 2012;2:828. [PMID: 23145321 DOI: 10.1038/srep00828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
31 Wu Z, Cho H, Hampton GM, Theodorescu D. Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis. Neoplasia 2009;11:66-76. [PMID: 19107233 DOI: 10.1593/neo.81048] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
32 Dannenberg JH, te Riele HP. The retinoblastoma gene family in cell cycle regulation and suppression of tumorigenesis. Results Probl Cell Differ 2006;42:183-225. [PMID: 16903212 DOI: 10.1007/400_002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
33 Kannan M, Jayamohan S, Moorthy RK, Chabattula SC, Ganeshan M, Arockiam AJV. AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway. Int J Mol Sci 2019;20:E5526. [PMID: 31698701 DOI: 10.3390/ijms20225526] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
34 Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast. Biochem J 2005;390:613-23. [PMID: 15913452 DOI: 10.1042/BJ20050574] [Cited by in Crossref: 70] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
35 Wang L, Ignat A, Axiotis CA. Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors: progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms. Appl Immunohistochem Mol Morphol 2002;10:139-46. [PMID: 12051632 DOI: 10.1097/00129039-200206000-00008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
36 Sagana RL, Yan M, Cornett AM, Tsui JL, Stephenson DA, Huang SK, Moore BB, Ballinger MN, Melonakos J, Kontos CD, Aronoff DM, Peters-Golden M, White ES. Phosphatase and tensin homologue on chromosome 10 (PTEN) directs prostaglandin E2-mediated fibroblast responses via regulation of E prostanoid 2 receptor expression. J Biol Chem 2009;284:32264-71. [PMID: 19808686 DOI: 10.1074/jbc.M109.004796] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
37 Tao S, Wang W, Liu P, Wang H, Chen W. Long non-coding RNA T-cell leukemia/lymphoma 6 serves as a sponge for miR-21 modulating the cell proliferation of retinoblastoma through PTEN. Korean J Physiol Pharmacol 2019;23:449-58. [PMID: 31680766 DOI: 10.4196/kjpp.2019.23.6.449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Barber A, Farmer K, Martin KR, Smith PD. Retinal regeneration mechanisms linked to multiple cancer molecules: A therapeutic conundrum. Prog Retin Eye Res 2017;56:19-31. [PMID: 27586058 DOI: 10.1016/j.preteyeres.2016.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
39 Dosil MA, Mirantes C, Eritja N, Felip I, Navaridas R, Gatius S, Santacana M, Colàs E, Moiola C, Schoenenberger JA, Encinas M, Garí E, Matias-guiu X, Dolcet X. Palbociclib has antitumour effects on Pten- deficient endometrial neoplasias: Inhibition of cyclin D-CDK4/6 axis in Pten -deficient neoplasias. J Pathol 2017;242:152-64. [DOI: 10.1002/path.4896] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
40 Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 2002;27:462-7. [PMID: 12217521 DOI: 10.1016/s0968-0004(02)02166-7] [Cited by in Crossref: 270] [Cited by in F6Publishing: 122] [Article Influence: 13.5] [Reference Citation Analysis]
41 Carico C, Nuño M, Mukherjee D, Elramsisy A, Dantis J, Hu J, Rudnick J, Yu JS, Black KL, Bannykh SI, Patil CG. Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide era. PLoS One 2012;7:e33684. [PMID: 22479427 DOI: 10.1371/journal.pone.0033684] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
42 Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol. 2003;23:6139-6149. [PMID: 12917336 DOI: 10.1128/mcb.23.17.6139-6149.2003] [Cited by in Crossref: 141] [Cited by in F6Publishing: 85] [Article Influence: 7.4] [Reference Citation Analysis]
43 Hao B, Shi A, Li X, Li J, Liu Z, Yuan H. miR-4516 inhibits the apoptosis of RB tumor cells by targeting the PTEN/AKT signaling pathway. Exp Eye Res 2020;200:108224. [PMID: 32919989 DOI: 10.1016/j.exer.2020.108224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol 2007; 13(40): 5299-5305 [PMID: 17879397 DOI: 10.3748/wjg.v13.i40.5299] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 4.3] [Reference Citation Analysis]
45 Chang YJ, Zhou L, Binari R, Manoukian A, Mak T, McNeill H, Stambolic V. The Rho Guanine Nucleotide Exchange Factor DRhoGEF2 Is a Genetic Modifier of the PI3K Pathway in Drosophila. PLoS One 2016;11:e0152259. [PMID: 27015411 DOI: 10.1371/journal.pone.0152259] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
46 Costa C, Paramio JM, Santos M. Skin Tumors Rb(eing) Uncovered. Front Oncol 2013;3:307. [PMID: 24381932 DOI: 10.3389/fonc.2013.00307] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
47 Chen W, Harris DL, Joyce NC. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells. Experimental Eye Research 2005;81:570-80. [DOI: 10.1016/j.exer.2005.03.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
48 Xu J, Langefeld CD, Zheng SL, Gillanders EM, Chang BL, Isaacs SD, Williams AH, Wiley KE, Dimitrov L, Meyers DA, Walsh PC, Trent JM, Isaacs WB. Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage. Hum Genet 2004;115:255-62. [PMID: 15185141 DOI: 10.1007/s00439-004-1144-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
49 Wu W, Slomovitz BM, Soliman PT, Schmeler KM, Celestino J, Milam MR, Lu KH. Correlation of cyclin D1 and cyclin D3 overexpression with the loss of PTEN expression in endometrial carcinoma. Int J Gynecol Cancer 2006;16:1668-72. [PMID: 16884382 DOI: 10.1111/j.1525-1438.2006.00642.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
50 Walker GJ, Hayward NK. Pathways to melanoma development: lessons from the mouse. J Invest Dermatol 2002;119:783-92. [PMID: 12406321 DOI: 10.1046/j.1523-1747.2002.00217.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
51 Vaisman CE, Del Moral-Hernandez O, Moreno-Campuzano S, Aréchaga-Ocampo E, Bonilla-Moreno R, Garcia-Aguiar I, Cedillo-Barron L, Berumen J, Nava P, Villegas-Sepúlveda N. C33-A cells transfected with E6*I or E6*II the short forms of HPV-16 E6, displayed opposite effects on cisplatin-induced apoptosis. Virus Res 2018;247:94-101. [PMID: 29452161 DOI: 10.1016/j.virusres.2018.02.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
52 Kim S, Domon-dell C, Kang J, Chung DH, Freund J, Evers BM. Down-regulation of the Tumor Suppressor PTEN by the Tumor Necrosis Factor-α/Nuclear Factor-κB (NF-κB)-inducing Kinase/NF-κB Pathway Is Linked to a Default IκB-α Autoregulatory Loop. Journal of Biological Chemistry 2004;279:4285-91. [DOI: 10.1074/jbc.m308383200] [Cited by in Crossref: 79] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
53 Sheng H, Shao J, DuBois RN. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J Biol Chem 2001;276:14498-504. [PMID: 11278613 DOI: 10.1074/jbc.M010093200] [Cited by in Crossref: 67] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
54 Kim K. Multifunctional Role of Fas-Associated Death Domain Protein in Apoptosis. BMB Reports 2002;35:1-6. [DOI: 10.5483/bmbrep.2002.35.1.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
55 Herlihy SE, Tang Y, Gomer RH. A Dictyostelium secreted factor requires a PTEN-like phosphatase to slow proliferation and induce chemorepulsion. PLoS One 2013;8:e59365. [PMID: 23555023 DOI: 10.1371/journal.pone.0059365] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
56 Brandmaier A, Hou SQ, Shen WH. Cell Cycle Control by PTEN. J Mol Biol 2017;429:2265-77. [PMID: 28602818 DOI: 10.1016/j.jmb.2017.06.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 8.6] [Reference Citation Analysis]
57 Knudsen ES, Pajak TF, Qeenan M, McClendon AK, Armon BD, Schwartz GF, Witkiewicz AK. Retinoblastoma and phosphate and tensin homolog tumor suppressors: impact on ductal carcinoma in situ progression. J Natl Cancer Inst 2012;104:1825-36. [PMID: 23197489 DOI: 10.1093/jnci/djs446] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
58 Phin S, Moore MW, Cotter PD. Genomic Rearrangements of PTEN in Prostate Cancer. Front Oncol 2013;3:240. [PMID: 24062990 DOI: 10.3389/fonc.2013.00240] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 7.2] [Reference Citation Analysis]
59 Squarize CH, Castilho RM, Santos Pinto D Jr. Immunohistochemical evidence of PTEN in oral squamous cell carcinoma and its correlation with the histological malignancy grading system. J Oral Pathol Med 2002;31:379-84. [PMID: 12224530 DOI: 10.1034/j.1600-0714.2002.00142.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.1] [Reference Citation Analysis]
60 He L, Fan C, Gillis A, Feng X, Sanatani M, Hotte S, Kapoor A, Tang D. Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma. Biochim Biophys Acta 2007;1772:1134-42. [PMID: 17681738 DOI: 10.1016/j.bbadis.2007.07.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
61 Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. Biochem Biophys Res Commun. 2002;292:422-426. [PMID: 11906179 DOI: 10.1006/bbrc.2002.6662] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
62 Tong J, Zhang H, Sun D, Wang Y, Yang C, Liu Y. Over-expression of PTEN on proliferation and apoptosis in canine mammary tumors cells. Animal Cells and Systems 2016;20:325-34. [DOI: 10.1080/19768354.2016.1256833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Roymans D, Slegers H. Phosphatidylinositol 3-kinases in tumor progression. Eur J Biochem 2001;268:487-98. [PMID: 11168386 DOI: 10.1046/j.1432-1327.2001.01936.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 120] [Article Influence: 6.3] [Reference Citation Analysis]
64 Yadav SS, Li J, Lavery HJ, Yadav KK, Tewari AK. Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment. Urol Oncol 2015;33:267.e1-13. [PMID: 25791755 DOI: 10.1016/j.urolonc.2015.02.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
65 Delou JMA, Souza ASO, Souza LCM, Borges HL. Highlights in Resistance Mechanism Pathways for Combination Therapy. Cells 2019;8:E1013. [PMID: 31480389 DOI: 10.3390/cells8091013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
66 Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R, Ansell PJ, Zhao J, Weng C, Klibanski A. Activation of p53 by MEG3 non-coding RNA. J Biol Chem. 2007;282:24731-24742. [PMID: 17569660 DOI: 10.1074/jbc.m702029200] [Cited by in Crossref: 416] [Cited by in F6Publishing: 274] [Article Influence: 27.7] [Reference Citation Analysis]
67 Besson A, Yong VW. Mitogenic signaling and the relationship to cell cycle regulation in astrocytomas. J Neurooncol 2001;51:245-64. [PMID: 11407596 DOI: 10.1023/a:1010657030494] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
68 Jiang K, Zhong B, Ritchey C, Gilvary DL, Hong-geller E, Wei S, Djeu JY. Regulation of Akt-dependent cell survival by Syk and Rac. Blood 2003;101:236-44. [DOI: 10.1182/blood-2002-04-1251] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 2.6] [Reference Citation Analysis]
69 White ES, Atrasz RG, Hu B, Phan SH, Stambolic V, Mak TW, Hogaboam CM, Flaherty KR, Martinez FJ, Kontos CD, Toews GB. Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 2006;173:112-21. [PMID: 16179636 DOI: 10.1164/rccm.200507-1058OC] [Cited by in Crossref: 144] [Cited by in F6Publishing: 95] [Article Influence: 8.5] [Reference Citation Analysis]
70 Yoganathan T, Costello P, Chen X, Jabali M, Yan J, Leung D, Zhang Z, Yee A, Dedhar S, Sanghera J. Integrin-linked kinase (ILK): a “hot” therapeutic target. Biochemical Pharmacology 2000;60:1115-9. [DOI: 10.1016/s0006-2952(00)00444-5] [Cited by in Crossref: 64] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
71 Sun S, Steinberg BM. PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells. J Gen Virol 2002;83:1651-8. [PMID: 12075083 DOI: 10.1099/0022-1317-83-7-1651] [Cited by in Crossref: 82] [Cited by in F6Publishing: 72] [Article Influence: 4.1] [Reference Citation Analysis]
72 Supsavhad W, Hassan BB, Simmons JK, Dirksen WP, Elshafae SM, Kohart NA, Demirer AA, Rosol TJ. Effect of Dickkopf-1 (Dkk-1) and SP600125, a JNK Inhibitor, on Wnt Signaling in Canine Prostate Cancer Growth and Bone Metastases. Vet Sci 2021;8:153. [PMID: 34437475 DOI: 10.3390/vetsci8080153] [Reference Citation Analysis]
73 Pamuk F, Cetinkaya BO, Gulbahar MY, Gacar A, Keles GC, Erisgin Z, Arik N. Effects of tacrolimus and nifedipine, alone or in combination, on gingival tissues. J Periodontol. 2013;84:1673-1682. [PMID: 23289868 DOI: 10.1902/jop.2013.120545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
74 Guo ZY, Hao XH, Tan FF, Pei X, Shang LM, Jiang XL, Yang F. The elements of human cyclin D1 promoter and regulation involved. Clin Epigenetics 2011;2:63-76. [PMID: 22704330 DOI: 10.1007/s13148-010-0018-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
75 Ago K, Saegusa Y, Nishimura J, Dewa Y, Kemmochi S, Kawai M, Harada T, Mitsumori K, Shibutani M. Involvement of glycogen synthase kinase-3β signaling and aberrant nucleocytoplasmic localization of retinoblastoma protein in tumor promotion in a rat two-stage thyroid carcinogenesis model. Experimental and Toxicologic Pathology 2010;62:269-80. [DOI: 10.1016/j.etp.2009.04.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]